Adipose Derived Stem Cell Therapy Market Driven by Growing Research into Medical Applications of cell therapy | Industry Analysis by Size, Overview, Research Report, Key Trends, Business Opportunity and Challenges

Adipose-derived stem cells (ADSCs) are a part of stem cells that are derived from adipocytes and can differentiate into a variety of cell types. They have multipotency like bone marrow mesenchymal stem cells, therefore they are also considered as a substitute for bone marrow as a source of stem cells.

Adipose stem cells (ASCs) can be extracted from adipose by manual as well as automatic stem cell separation technique and flow cytometry is the most common method employed to isolate ADSCs from other stem cells within a cell solution.

Adipose-derived stem cells are gaining demand as a new cell source in regenerative medicine therapies as they can be differentiated into a variety of different cell lineages. Moreover, these stem cells also have anti-inflammatory, immunomodulatory, anti-apoptotic, pro-angiogenic, and anti-scarring properties, which improve their effectiveness and expand their application.

Adipose-Derived Stem Cell Therapy Market Drivers

Growing demand for adipose-derived stem cell therapy across medical and biotechnology fields owing to its effectiveness along with a rising number of research and development in activities by the various organizations is projected to foster the market growth of adipose-derived stem cell therapy over the forecast period. Adipose-derived stem cells (ADSCs) have expanded to various applications in medical and biomedical science field such as treatment of diabetes; regeneration of tissues partially in osteogenic, adipogenic, chondrogenic, and cardiovascular areas of medicine; bone regeneration; fat reconstruction; and myocardial and cardiovascular regeneration; among others

For instance, in November 2018, a peer-reviewed case study conducted using a stem cell processed by Celltex Therapeutics Corporation showed the improvement in disease findings following systemic administration of autologous adipose-derived mesenchymal stem cells (MSCs).

Adipose-Derived Stem Cell Therapy Market Regional Analysis

North America is projected to hold a dominant position in the global adipose-derived stem cell therapy market and account the largest market share during the forecast period, and this can be attributed to strong presence of key players in the region, which are actively engaged in research & development activities and implementing inorganic growth strategies such as acquisition and collaboration to increase its market share.

For instance, in December 2017, Mesoblast Limited made exclusive license agreement with TiGenix NV, through which Mesoblast granted TiGenix exclusive access to certain of its patents to support global commercialization of Cx601, adipose-derived mesenchymal stem cell product, for the local treatment of fistulae.

Adipose-Derived Stem Cell Therapy Market Restraint

On the other side, high costs associated with stem cell processing, lack of skilled professionals for managing, preserving, and monitoring of stem cell lines are expected to restrain the market growth of adipose-derived stem cell therapy market during the forecast period.

For instance, Bioinformant— a research firm engaged in stem cell research— released a data on November 2018, on the cost of stem cell therapy and various key factors impacting the cost of stem cell therapy including types of stem cells used within the procedure, number of treatment, and the site of the clinic. The study findings reveal the cost of stem cell therapy ranges between US$ 5,000-8,000 per patient, in some cases, it may raise as much as US$ 25,000 or more depending on the complexity of the procedure.

Adipose-Derived Stem Cell Therapy Market Key Players

Key players operating in the global adipose-derived stem cell therapy market include BioRestorative Therapies, Inc., Celltex Therapeutics Corporation, Antria, Inc., Cytori Therapeutics Inc., Intrexon Corporation, Mesoblast Ltd., iXCells Biotechnologies, Pluristem Therapeutics, Inc., Thermo Fisher Scientific, Inc., Tissue Genesis, Inc., Cyagen US Inc., Celprogen, Inc., and Lonza Group, among others.

Adipose-Derived Stem Cell Therapy Market Taxonomy:

The global adipose-derived stem cell therapy market is segmented based on cell type, product type, application, end-user, and region.

By Cell Type

  • Allogeneic Stem Cells
  • Autologous Stem Cells

By Product Type

  • Cell lines
  • Culture Media

By Application


  • Therapeutic Application
  • Research Application

By End-User

  • Cell & Tissue Banks
  • Biotechnology & Pharmaceutical organizations
  • Research & Academic Organizations

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa